Endocrine screening for sexual dysfunction using free testosterone determinations.

[1]  D. Cummings,et al.  Prospects for new hormonal male contraceptives. , 1994, Endocrinology and metabolism clinics of North America.

[2]  A. Morales,et al.  Oral androgens in the treatment of hypogonadal impotent men. , 1994, The Journal of urology.

[3]  J. Jarow,et al.  Is routine endocrine testing of impotent men necessary? , 1992, The Journal of urology.

[4]  R. Foster,et al.  Role of serum prolactin determination in evaluation of impotent patient. , 1990, Urology.

[5]  P. Marrama,et al.  Effects of androgen treatment in impotent men with normal and low levels of free testosterone , 1990, Archives of sexual behavior.

[6]  Baskin Hj.  Endocrinologic evaluation of impotence. , 1989 .

[7]  Mcclure Rd.  Endocrine evaluation and therapy of erectile dysfunction. , 1988 .

[8]  T. Maatman,et al.  Cost-effective evaluation of impotence. , 1986, Urology.

[9]  J. Nickel,et al.  Endocrine dysfunction in impotence: incidence, significance and cost-effective screening. , 1984, The Journal of urology.

[10]  F. Nuttall,et al.  Impotence in medical clinic outpatients. , 1983, JAMA.

[11]  S. Mulholland,et al.  A multidisciplinary approach to the evaluation and management of male sexual dysfunction. , 1983, The Journal of urology.

[12]  P. Connolly,et al.  Impotence is not always psychogenic. Newer insights into hypothalamic-pituitary-gonadal dysfunction. , 1980, JAMA.

[13]  J. Carter,et al.  Prolactin-screening tumors and hypogonadism in 22 men. , 1978, The New England journal of medicine.

[14]  S. Franks,et al.  HYPERPROLACTINAEMIA AND IMPOTENCE , 1978, Clinical endocrinology.